Cinryze (ViroPharma Biologics)
Welcome to the PulseAid listing for the Cinryze drug offered from ViroPharma Biologics. This Human C1 Esterase Inhibitor [EPC],Decreased Vascular Permeability [PE],Kallikrein Inhibitors [MoA] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | ViroPharma Biologics |
| NON-PROPRIETARY NAME: | HUMAN C1-ESTERASE INHIBITOR |
| SUBSTANCE NAME: | HUMAN C1-ESTERASE INHIBITOR |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | Human C1 Esterase Inhibitor [EPC],Decreased Vascular Permeability [PE],Kallikrein Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2008-12-01 |
| END MARKETING DATE: | 0000-00-00 |
Cinryze PLASMA DERIVATIVE Details:
| Item Description | Cinryze from ViroPharma Biologics |
| LABELER NAME: | ViroPharma Biologics |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500([iU]/5mL) |
| START MARKETING DATE: | 2008-12-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 42227-081_8096f203-a205-4df5-9e87-fea4372d6698 |
| PRODUCT NDC: | 42227-081 |
| APPLICATION NUMBER: | BLA125267 |
Other HUMAN C1-ESTERASE INHIBITOR Pharmaceutical Manufacturers / Labelers:
